Rodney Brenneman, CEO and President
Rodney Brenneman has 24 years of experience in the medical device industry. He co-founded ROX Medical in 2004. Prior to ROX Medical Mr. Brenneman worked for USGI Medical as Vice President of R&D. At USGI he led a team of nine engineers and technicians to develop devices for endo-luminal GI surgery. Mr. Brenneman co-founded TheraCardia in 1998 and served as VP of R&D and Operations until 2003. Prior to 1998, Mr. Brenneman worked for Vesica Medical, acquired by Boston Scientific, Corp in 1996 and Advanced Surgical Intervention acquired by Boston Scientific, Corp in 1993. Mr. Brenneman has also done considerable consulting for very early stage medical device companies in a wide variety of specialties including Cardiology, Orthopedics, Urology, Opthamology, Neurology and Interventional Radiology.
Paul Sobotka, MD, Chief Scientific Officer
Paul Alan Sobotka, M.D., F.A.C.C., F.A.C.P., F.A.H.A., Chief Medical Officer of ROX, Inc. Graduated from Stanford University with degree in Chemistry and obtained his Medical Degree from the University of Illinois College of Medicine. Dr. Sobotka completed training in Internal Medicine at The University of Michigan, followed by specialty training in cardiovascular diseases at Northwestern University. He holds an appointment as Clinical Professor of Medicine/Cardiology at The Ohio State University.
Dr. Sobotka has authored nearly 200 peer reviewed manuscripts and book chapters including manuscripts published in: The Journal Clinical Investigation, American Journal of Physiology, The New England Journal of Medicine, Circulation: The Lancet, Circulation: Heart Failure, Journal of Congestive Failure, Hypertension, Journal of Hypertension, Journal of the American Society of Nephrology, and Journal of Congestive Heart Failure.
Charles Love, Sr. Vice President of Global Clinical Operations and Regulatory Affairs
Charles “Chuck” Love is the Senior Vice President of Global Clinical Operations and Regulatory Affairs. Chuck has held a variety of senior executive roles for both large a small medical device companies. Prior to joining ROX Medical Chuck served as Vice President of Clinical Affairs at Endologix where he and his team managed the clinical evidence program involving more 3,000 patients in active clinical studies. Chuck led the clinical team at CoreValve prior to its acquisition by Medtronic, and then worked with Medtronic on the integration of CoreValve and subsequent acquisition and integration of ATS Medical. He has founded two medical device companies in the structural heart space, and is an active board member including Loma Vista Medical which was successfully acquired by CR Bard. Chuck received his B.A. in Biology from Westmont College. He also completed undergraduate work in Engineering at Gonzaga University and completed management programs at the University of California and Stanford University. He holds numerous patents, is published in peer-reviewed journals, and has presented original data at major medical society meetings.